research data . Clinical Trial . 2011

Mesenchymal Stem Cells After Renal or Liver Transplantation

Beguin, Yves;
Open Access
  • Published: 01 Sep 2011
  • Publisher: nct
The present project aims at evaluating the safety and tolerability of third party MSC administration after liver or kidney organ transplantation. Ten patients undergoing liver transplantation and 10 patients undergoing kidney transplantation will be included in the experimental arm to receive a single infusion of MSC. The outcome of each of these 2 subgroups will be compared with that of similar control patients undergoing liver or kidney transplantation but who will not receive MSC. Liver and kidney transplanted patients will receive standard immunosuppressive therapy, TAC-MMF-steroïds and TAC-MMF-steroïds plus an IL-2-R antibody respectively. Patients enrolled...
Medical Subject Headings: surgical procedures, operative
Download from
Clinical Trial . 2011
Provider: OpenTrials
Any information missing or wrong?Report an Issue